ACT Capital Management »

Alumis shares owned by ACT Capital Management

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8M 174k 22.03

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Celcuity (CELC)
Tg Therapeutics (TGTX)
Abivax Sa Sponsored Ads (ABVX)
Amazon (AMZN)
Viking Therapeutics (VKTX)
Arrowhead Pharmaceuticals (ARWR)
Nektar Therapeutics Com New (NKTR)
Cytokinetics (CYTK)
Alumis (ALMS)
Energy Transfer Com Ut Ltd Ptn (ET)
Freeport-McMoRan Copper & Gold (FCX)
Applied Optoelectronics (AAOI)

View all positions for ACT Capital Management

Top funds holding Alumis

AyurMaya Capital Management Company
Foresite Capital Management V
Samsara BioCapital
venBio Partners
BlackRock
Foresite Capital Management VI
Vanguard Group
Vanguard Capital Management
Cormorant Asset Management
Saturn V Capital Management
UBS Group
Nextech Invest
Octagon Capital Advisors
MPM Oncology Impact Management
Sr One Capital Management

View all funds holding Alumis